Literature DB >> 32064109

Significance of a preoperative tumor marker gradient for predicting microvascular invasion in cases of hepatocellular carcinoma.

Satoshi Koizumi1, Shingo Yamashita2, Satoshi Matsumura3, Kazuhisa Takeda4, Takuya Minagawa5, Shinjiro Kobayashi1, Taizo Hibi5,6, Masahiro Shinoda5, Itaru Endo4, Minoru Tanabe3, Masakazu Yamamoto2, Takehito Otsubo1.   

Abstract

Although vascular invasion is an important factor in the progression and treatment of hepatocellular carcinoma (HCC), it remains difficult to determine, on the basis of preoperative imaging alone, whether vascular invasion, especially microvascular invasion, has occurred. The current retrospective study enrolled 292 patients who, between 2004 and 2014, underwent curative hepatectomy as an initial treatment for HCC. The patients were divided between those with (n=70) and those without (n=222) microvascular invasion. Whether tumor-marker-based prediction of microvascular invasion was possible was assessed by comparing the preoperative serum α-fetoprotein (AFP) and prothrombin induced by vitamin K absence or antagonist-II concentrations between two groups of patients. The AFP concentration was significantly higher in patients with microvascular invasion compared with patients without microvascular invasion (P=0.0019). Stepwise logistic regression analysis demonstrated the AFP concentration and the logarithmic conversion ratio of the AFP gradient (log AFP grad) to be useful (P=0.0019; 0.0424) for predicting microvascular invasion. The serum AFP concentration and log AFP grad appear to be clinically useful in predicting microvascular invasion in patients with HCC.
Copyright © 2019, Spandidos Publications.

Entities:  

Keywords:  microvascular invasion; tumor marker; α-fetoproteingradient

Year:  2020        PMID: 32064109      PMCID: PMC7016610          DOI: 10.3892/mco.2020.1975

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  8 in total

1.  Predictors of microvascular invasion before hepatectomy for hepatocellular carcinoma.

Authors:  Masaki Kaibori; Morihiko Ishizaki; Kosuke Matsui; A-Hon Kwon
Journal:  J Surg Oncol       Date:  2010-10-01       Impact factor: 3.454

2.  Clinicopathologic characteristics of patients with non-B non-C hepatitis virus hepatocellular carcinoma after hepatectomy.

Authors:  Masaki Kaibori; Morihiko Ishizaki; Kosuke Matsui; A-Hon Kwon
Journal:  Am J Surg       Date:  2012-05-15       Impact factor: 2.565

Review 3.  Clinical and molecular insights into the hepatocellular carcinoma tumour marker des-γ-carboxyprothrombin.

Authors:  Yoshinori Inagaki; Wei Tang; Masatoshi Makuuchi; Kiyoshi Hasegawa; Yasuhiko Sugawara; Norihiro Kokudo
Journal:  Liver Int       Date:  2010-09-27       Impact factor: 5.828

4.  Outcomes and predictors of microvascular invasion of solitary hepatocellular carcinoma.

Authors:  Fumitoshi Hirokawa; Michihiro Hayashi; Yoshiharu Miyamoto; Mitsuhiro Asakuma; Tetsunosuke Shimizu; Koji Komeda; Yoshihiro Inoue; Kazuhisa Uchiyama
Journal:  Hepatol Res       Date:  2013-08-19       Impact factor: 4.288

5.  A non-smooth tumor margin in the hepatobiliary phase of gadoxetic acid disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging predicts microscopic portal vein invasion, intrahepatic metastasis, and early recurrence after hepatectomy in patients with hepatocellular carcinoma.

Authors:  Shun-ichi Ariizumi; Koichi Kitagawa; Yoshihito Kotera; Yutaka Takahashi; Satoshi Katagiri; Ryohei Kuwatsuru; Masakazu Yamamoto
Journal:  J Hepatobiliary Pancreat Sci       Date:  2011-07       Impact factor: 7.027

6.  Positive status of alpha-fetoprotein and des-gamma-carboxy prothrombin: important prognostic factor for recurrent hepatocellular carcinoma.

Authors:  Masaki Kaibori; Yoichi Matsui; Hidesuke Yanagida; Norio Yokoigawa; A-Hon Kwon; Yasuo Kamiyama
Journal:  World J Surg       Date:  2004-06-08       Impact factor: 3.352

7.  A review of the prognostic factors in patients with recurrence after liver resection for hepatocellular carcinoma.

Authors:  Masaki Kaibori; Takamichi Saito; Yoichi Matsui; Yoichiro Uchida; Morihiko Ishizaki; Yasuo Kamiyama
Journal:  Am J Surg       Date:  2007-04       Impact factor: 2.565

8.  Impact of PIVKA-II in diagnosis of hepatocellular carcinoma.

Authors:  Nadia I Zakhary; Sherif M Khodeer; Hanan E Shafik; Camelia A Abdel Malak
Journal:  J Adv Res       Date:  2013-01-11       Impact factor: 10.479

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.